Clinical Trial Update: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated temozolomide in combination with cixutumumab and chemotherapy for metastatic rhabdomyosarcoma; the study has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Rhabdomyosarcoma
• Embryonal Rhabdomyosarcoma
• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Cixutumumab (Cixutumumab)
• Combination chemotherapy (unspecified)
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2017-07-28